Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$155.22 - $162.74 $118,898 - $124,658
766 New
766 $121,000
Q3 2023

Oct 12, 2023

SELL
$155.75 - $174.48 $4,828 - $5,408
-31 Reduced 2.32%
1,306 $203,000
Q2 2023

Jul 11, 2023

SELL
$154.35 - $166.11 $2,469 - $2,657
-16 Reduced 1.18%
1,337 $221,000
Q1 2023

Apr 17, 2023

BUY
$151.05 - $180.26 $3,474 - $4,145
23 Added 1.73%
1,353 $209,000
Q4 2022

Jan 18, 2023

BUY
$160.2 - $179.79 $8,009 - $8,989
50 Added 3.91%
1,330 $0
Q3 2022

Oct 28, 2022

SELL
$161.33 - $179.52 $10,647 - $11,848
-66 Reduced 4.9%
1,280 $209,000
Q2 2022

Jul 26, 2022

SELL
$168.19 - $186.01 $1,681 - $1,860
-10 Reduced 0.74%
1,346 $239,000
Q1 2022

Apr 18, 2022

BUY
$158.14 - $179.59 $5,218 - $5,926
33 Added 2.49%
1,356 $240,000
Q3 2021

Oct 19, 2021

SELL
$161.5 - $179.47 $19,218 - $21,356
-119 Reduced 8.25%
1,323 $214,000
Q2 2021

Jul 22, 2021

BUY
$159.48 - $171.07 $15,947 - $17,107
100 Added 7.45%
1,442 $238,000
Q1 2021

Apr 20, 2021

BUY
$153.07 - $170.48 $205,419 - $228,784
1,342 New
1,342 $221,000
Q4 2020

Jan 26, 2021

SELL
$137.11 - $157.38 $143,828 - $165,091
-1,049 Closed
0 $0
Q3 2020

Oct 21, 2020

BUY
$140.38 - $153.83 $147,258 - $161,367
1,049 New
1,049 $156,000
Q4 2019

Jan 27, 2020

SELL
$127.5 - $146.44 $131,070 - $150,540
-1,028 Closed
0 $0
Q3 2019

Oct 30, 2019

SELL
$126.95 - $142.14 $4.47 Million - $5.01 Million
-35,247 Reduced 97.17%
1,028 $133,000
Q2 2019

Jul 25, 2019

SELL
$131.15 - $144.24 $193,577 - $212,898
-1,476 Reduced 3.91%
36,275 $5.05 Million
Q1 2019

Apr 25, 2019

BUY
$125.72 - $139.79 $148,726 - $165,371
1,183 Added 3.24%
37,751 $5.28 Million
Q4 2018

Jan 28, 2019

BUY
$122.84 - $147.84 $23,830 - $28,680
194 Added 0.53%
36,568 $4.72 Million
Q3 2018

Oct 22, 2018

SELL
$121.58 - $142.88 $100,303 - $117,876
-825 Reduced 2.22%
36,374 $5.03 Million
Q2 2018

Jul 25, 2018

BUY
$119.4 - $131.76 $213,487 - $235,586
1,788 Added 5.05%
37,199 $4.51 Million
Q1 2018

Apr 13, 2018

SELL
$125.1 - $148.14 $111,964 - $132,585
-895 Reduced 2.47%
35,411 $4.54 Million
Q4 2017

Feb 01, 2018

BUY
$131.22 - $143.62 $56,687 - $62,043
432 Added 1.2%
36,306 $5.07 Million
Q3 2017

Oct 30, 2017

BUY
$129.47 - $135.38 $4.64 Million - $4.86 Million
35,874
35,874 $4.66 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Northwest Investment Counselors, LLC Portfolio

Follow Northwest Investment Counselors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Investment Counselors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Investment Counselors, LLC with notifications on news.